An Allentown company, U.S. Specialty Formulations, is developing a new oral COVID-19 vaccine that promises to expand the number of people vaccinated around the world. The vaccine is undergoing clinical trials now. Grover Silcox reports.
Read More
An Allentown company, U.S. Specialty Formulations, is developing a new oral COVID-19 vaccine that promises to expand the number of people vaccinated around the world. The vaccine is undergoing clinical trials now. Grover Silcox reports.
Read MoreWritten by the GamePlanX Network of Experts - https://gameplanx.com, a multidisciplinary team specializing in outcome‑driven strategic growth, regulatory‑compliant digital marketing, and AI‑enabled operational optimization across industries. For this article, the GamePlanX team contributes expertise specifically relevant to USSF’s cGMP pharmaceutical manufacturing operations, botanical injectables, and clinical education initiatives.